So long as one doesn't cannibalise another.

First 25 Last

Share
Profile

Follow
johndprent

2,738 Posts.

3342

14/12/21

19:19

Post #: 58291535
Share

Originally posted by Gorey29: ↑

Is it possible we could have more than one concurrent pharma partnership if, for some, their main objective is just achieving licensing for a drug combination?

Being new to this area, it's been interesting to think about as initially, my thoughts are pharma companies looking to partner with Race might not mind if we have another active partnership as long as there is no competing interest i.e not targeting the same cancer market as the other partner or in the same drug class and if Race can manage sufficient resource allocation that they are after between them...

With these factors in mind, I do understand why such a thing might not take place. However, given the size of our Race team, they have been able to achieve an exceptional amount of work and have many activities happening in a lot of different locations which I think speaks to the resource allocation factor in a way.

It would be interesting to know what the logistics around this are and the reality of whether this could take place or not.

I didn't have much luck searching for instances of this and had to be careful with my keywords, as I got a lot of results for 'sexual risk factors' to start with when searching for concurrent pharma partnerships lol

Expand

So long as one doesn't cannibalise another.

RAC Price at posting: $3.42 Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

BIO

Biome unveils three year revenue target up to $85M – but are 3Y targets enough to excite?

IVZ

Invictus banks US$5M from Zimbabwean investment fund in support of Cabora Bassa

AZL

Brine and shine: Arizona Lithium wins early stage eco approval to commence wellpad #2 at Prairie

PAM

PAM secures high-grade Chilean copper play in strong territory

BOE

$550 million Jabiluka uranium offer comes unstuck as Government rules lease won't be renewed

There are more pages in this discussion • 58 more messages in this thread...

First 25 Last

Add RAC (ASX) to my watchlist

(20min delay)
Last $1.61		Change 0.000(0.00%)		Mkt cap ! $273.4M

Open	High	Low	Value	Volume
$1.61	$1.66	$1.60	$207.2K	127.1K

Buyers (Bids)

No.	Vol.	Price($)
6	25510	$1.60

Sellers (Offers)

Price($)	Vol.	No.
$1.64	12000	1

View Market Depth

No.	Vol.	Price($)
6	25510	1.600
1	31000	1.590
1	10000	1.585
2	8233	1.560
4	15571	1.550

Price($)	Vol.	No.
1.640	12000	1
1.655	858	1
1.665	352	1
1.670	1845	1
1.690	1085	2

Last trade - 15.49pm 29/07/2024 (20 minute delay)

RAC (ASX) Chart

So long as one doesn't cannibalise another.

Biome unveils three year revenue target up to $85M – but are 3Y targets enough to excite?

Invictus banks US$5M from Zimbabwean investment fund in support of Cabora Bassa

Brine and shine: Arizona Lithium wins early stage eco approval to commence wellpad #2 at Prairie

PAM secures high-grade Chilean copper play in strong territory

$550 million Jabiluka uranium offer comes unstuck as Government rules lease won't be renewed

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

So long as one doesn&apos;t cannibalise another.

Top Stories

Biome unveils three year revenue target up to $85M – but are 3Y targets enough to excite?

Invictus banks US$5M from Zimbabwean investment fund in support of Cabora Bassa

Brine and shine: Arizona Lithium wins early stage eco approval to commence wellpad #2 at Prairie

PAM secures high-grade Chilean copper play in strong territory

$550 million Jabiluka uranium offer comes unstuck as Government rules lease won't be renewed

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

So long as one doesn't cannibalise another.